1. Combes A, Brodie D, Bartlett R, Brochard L, Brower R, Conrad S, De Backer D, Fan E, Ferguson N, Fortenberry J, Fraser J, Gattinoni L, Lynch W, MacLaren G, Mercat A, Mueller T, Ogino M, Peek G, Pellegrino V, Pesenti A, Ranieri M, Slutsky A, Vuylsteke A. Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients. Am J Respir Crit Care Med 2014; 190: 488-496.
2. Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999; 23: 979-983.
3. Annich G, Adachi I. Anticoagulation for pediatric mechanical circulatory support. Pediatr Crit Care Med 2013; 14: S37-42.
4. Dalton HJ, Garcia-Filion P, Holubkov R, Moler FW, Shanley T, Heidemann S, Meert K, Berg RA, Berger J, Carcillo J, Newth C, Harrison R, Doctor A, Rycus P, Dean JM, Jenkins T, Nicholson C. Association of bleeding and thrombosis with outcome in extracorporeal life support. Pediatr Crit Care Med 2015; 16: 167-174.
5. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009; 13: 154-175.
6. ELSO Anticoagulation Guideline 2014. 2014.
7. Opal SM, Kessler CM, Roemisch J, Knaub S. Antithrombin, heparin, and heparan sulfate. Crit Care Med 2002; 30: S325-331.
8. Pratt CW, Church FC. Antithrombin: structure and function. Semin Hematol 1991; 28: 3-9.
9. Maclean PS, Tait RC. Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options. Drugs 2007; 67: 1429-1440.
10. Panigada M, Iapichino G, L'Acqua C, Protti A, Cressoni M, Consonni D, Mietto C, Gattinoni L. Prevalence of "Flat-Line" Thromboelastography During Extracorporeal Membrane Oxygenation for Respiratory Failure in Adults. ASAIO J 2016; 62: 302-309.
11. Protti A, L'Acqua C, Panigada M. The delicate balance between pro-(risk of thrombosis) and anti-(risk of bleeding) coagulation during extracorporeal membrane oxygenation. Ann Transl Med 2016; 4: 139.
12. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K. Effects of antithrombin III (AT III) and Trp49-modified AT III on plasma level of 6-keto-PGF1 alpha in rats. Thromb Res 1995; 80: 201-208.
13. Roemisch J, Gray E, Hoffmann JN, Wiedermann CJ. Antithrombin: a new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis 2002; 13: 657-670.
14. Wang J, Wang Y, Gao J, Tong C, Manithody C, Li J, Rezaie AR. Antithrombin is protective against myocardial ischemia and reperfusion injury. J Thromb Haemost 2013; 11: 1020-1028.
15. Isik S, Tuncyurek P, Zengin NI, Demirbag AE, Atalay F, Yilmaz S, Orug T. Antithrombin prevents apoptosis by regulating inflammation in the liver in a model of cold ischemia/warm reperfusion injury. Hepatogastroenterology 2012; 59: 453-457.
16. dos Santos CC, Okutani D, Hu P, Han B, Crimi E, He X, Keshavjee S, Greenwood C, Slutsky AS, Zhang H, Liu M. Differential gene profiling in acute lung injury identifies injury-specific gene expression. Crit Care Med 2008; 36: 855-865.
17. Wong TE, Delaney M, Gernsheimer T, Matthews DC, Brogan TV, Mazor R, McMullan DM, Reiner AP, Konkle BA. Antithrombin concentrates use in children on extracorporeal membrane oxygenation: a retrospective cohort study. Pediatr Crit Care Med 2015; 16: 264-269.
18. Niebler RA, Christensen M, Berens R, Wellner H, Mikhailov T, Tweddell JS. Antithrombin replacement during extracorporeal membrane oxygenation. Artif Organs 2011; 35: 1024-1028.
19. Byrnes JW, Swearingen CJ, Prodhan P, Fiser R, Dyamenahalli U. Antithrombin III supplementation on extracorporeal membrane oxygenation: impact on heparin dose and circuit life. ASAIO J 2014; 60: 57-62.
20. Nelson KM, Hansen LA, Steiner ME, Fischer GA, Dehnel J, Gupta S. Continuous Antithrombin III Administration in Pediatric Veno-Arterial Extracorporeal Membrane Oxygenation. J Pediatr Pharmacol Ther 2017; 22: 266-271.
21. Ryerson LM, Bauman ME, Kuhle S, Bruce AA, Massicotte MP. Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study. Pediatr Crit Care Med 2014; 15: e340-346.
22. Perry R, Stein J, Young G, Ramanathan R, Seri I, Klee L, Friedlich P. Antithrombin III administration in neonates with congenital diaphragmatic hernia during the first three days of extracorporeal membrane oxygenation. J Pediatr Surg 2013; 48: 1837-1842.
23. Agati S, Ciccarello G, Salvo D, Turla G, Undar A, Mignosa C. Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience. ASAIO J 2006; 52: 513-516.
24. Knod J, Kraus S, Donovan E, Burton K, Lipinski T, Cooper D, Frischer J. Continuous infusion of antithrombin III during Extracorporeal Mmbrane Oxygenation offers advantage over bolus dosing. American Academy of Pediatrics National Conference and Exhibition 2014.
25. Martucci G, Panarello G, Occhipinti G, Ferrazza V, Tuzzolino F, Bellavia D, Sanfilippo F, Santonocito C, Bertani A, Vitulo P, Pilato M, Arcadipane A. Anticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and Mortality. J Intensive Care Med 2017: 885066617706339.
26. Iapichino GE, Protti A, Andreis DT, Panigada M, Artoni A, Novembrino C, Pesenti A, Gattinoni L. Antithrombin During Extracorporeal Membrane Oxygenation in Adults: National Survey and Retrospective Analysis. ASAIO J 2018.